Vymedic

Neutral
BETA

Scientifically proven broad-spectrum antiviral beats industry-leading treatments in the suppression of flu, colds and common viruses.

Analytics

Raised to Date: $133,005

Aggregate Commitments $
Platform

Netcapital

Start Date

09/25/2020

Close Date

12/23/2020

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

Equity - Common

Funding Type

RegCF

Series

Pre-Seed

Pre-Money Valuation

$20,000,000

Weekly Commitments $
Status

Active

Reporting Date

11/30/2020

Days Remaining

21

% of Min. Goal

1,330%

% of Max. Goal

12%

Likelihood of Max
Avg. Daily Raise

$2,015

Momentum
Location

Englewood, CO

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2C

Margin

High

Capital Intensity

High

Business Type

Growth

Vymedic, with a post-money valuation of $23 million, is raising crowdfunding on NetCapital. The company has manufactured Vymune, a broad-spectrum antiviral, that beats other treatments in the suppression of influenza. Vymune is not strain-specific and activates the immune system against the illness. Cynthia Winning founded Vymedic in March 2020. The current crowdfunding round has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used for hiring, manufacturing, and marketing. The product of Vymedic is patented, natural, and made up of amino acids, bioflavonoids, and co-factors. It is safe to use for children, elderly, pregnant women, and immunosuppressed individuals.

Summary Profit and Loss Statement
Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-46,788

$-45,688

Summary Balance Sheet
Most Recent Year Prior Year

Cash

$2,032

$3,105

Accounts Receivable

$0

$0

Total Assets

$2,032

$3,105

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Ratings

last updated 12/01/2020

Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.
Other Deals

UpLyft on Wefunder

UpLyft has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
HealtheMed on Wefunder

HealtheMed has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Biopact on Equifund CFP

Biopact has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Vymedic on NetCapital
Follow company
Follow Vymedic on NetCapital